12. Lab Testing and Antepartal Fetal Surveillance Flashcards
Purpose of test: Blood Grouping
To determine blood type and Rh
Purpose of test: Hemoglobin or Hematocrit
To detect anemia. (Often checked several times during pregnancy)
Purpose of test: CBC
Complete Blood Count:
To detect infection, anemia, or cell abnormalities
Purpose of test: Rh Factor and Antibody Screen
To screen for possible maternal-fetal blood incompatibility
Purpose of test: VDRL or RPR
To screen for syphillis
Venereal Disease Research Laboratory, Rapid Plasma Reagin
Purpose of test: Rubella Titer
To determine immunity
Purpose of test: Tuberculin Skin Test
To screen for tuberculosis
Purpose of test: Hemoglobin Electrophoresis
To screen for sickle-cell trait (if client is African-American
Purpose of test: Hepatitis B
To detect presence of antigens in Maternal Blood
Purpose of test: HIV screen
Voluntary test encouraged to detect HIV antibodies
Purpose of test: Urinalysis
To detect renal disease or infection
Purpose of test: Papanicolau Test
To screen for cervical neoplasia
Purpose of test: Cervical Culture
To detect group B strep and STDs
Purpose of test: Triple Screen
To screen for fetal anomalies
What three tests comprise a “Triple Screen”
- Maternal serum alpha-fetorotein
- Human Chorionic Gonadotropin
- Estriol
Purpose of test: Maternal Blood Glucose
To screen for gestational diabetes
Test Significance / Course of Action: Blood Grouping
Identifies possible causes of incompatibility with the blood of the fetus that may cause jaundice
Test Significance / Course of Action: Hemoglobin or Hematocrit
Hgb < 11 g/dL or Hct < 33% may indicate a need for iron supplementation
Test Significance / Course of Action: CBC
12,000 mm3 or more white blood cells or decreased platelets require follow-up
Test Significance / Course of Action: Rh Factor and antibody screen
If mother is Rh (-) and Father is Rh (+) or antibodies are present, additional testing and treatment are required.
(If mom is negative, RhoGAM will be given at 26-28 weeks)
Test Significance / Course of Action: VDRL and RPR
Treat if positive; retest at 36 weeks
Test Significance / Course of Action: Rubella Titer
If titer is 1:8 or less, mother is not immune. Immunize post-partum if not immune.
Test Significance / Course of Action: Hemoglobin Electrophoresis
If mother is positive, check partner. Infant is at risk only if both parents are positive.
Test Significance / Course of Action: Hepatitis B
If present, infants should be given hepatitis immune globulin and vaccine soon after birth.
HIV Screen
Positive results require retesting, counseling, and treatment to lower infant infection
Test Significance / Course of Action: Urinalysis
Requires further assessment if positive for more than trace:
- Protein (renal damage, preeclampsia, or normal)
- Glucose (diabetes or normal)
- Ketones (Fasting or dehydration)
- Bacteria (Infection)
Test Significance / Course of Action: Pap Test
Treat and refer ib abnormal cells are present
Test Significance / Course of Action: Cervical Culture
- Treat and retest as necessary.
* Treat GBS during labor.
Test Significance / Course of Action: Triple Screen
Abnormal results may indicate Down Syndrome or neural tube defects.
Test Significance / Course of Action: Maternal Blood Glucose
If elevated, a 3-hour glucose tolerance test is recommended.
Test to be done in the 1st trimester
nuchal translucency screening +PAPP-A
When should the MSAFP Triple / Quad Screen be administered?
15-22 weeks
When should an ultrasound to check fetal anatomy be administered?
18-20 weeks